Toucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology
Business Model:
Revenue: $11.7M
Employees: 51-200
Address: 7600 Wisconsin Ave
City: Bethesda
State: MD
Zip: 20814
Country: US
Toucan Capital Fund II, L.P. is a $140 million venture capital fund focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is one of the largest and most active venture capital funds in seed and early-stage life science. Toucan has also been an early investor in nanotechnology. Toucan is especially active in the mid-Atlantic region, one of the richest markets in the country for life science and certain advanced technologies, and a market that has generally been underserved by venture capital.
Contact Phone:
+12404974060
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2004 | Reactive NanoTechnologies | Series B | 0 |
1/2008 | Reactive NanoTechnologies | Series C | 0 |
7/2004 | Intrapace | Series C | 0 |
5/2008 | Reactive NanoTechnologies | Series D | 0 |
6/2019 | INmuneBIO | Post-IPO Equity | 0 |
2/2008 | Q Therapeutics | Venture Round | 0 |
8/2004 | Pepgen | Series D | 0 |
1/2003 | Reactive NanoTechnologies | Series A | 0 |
6/2019 | INmuneBIO | Post-IPO Equity | 0 |
5/2008 | Reactive NanoTechnologies | Series D | 0 |
2/2008 | Q Therapeutics | Venture Round | 0 |
1/2008 | Reactive NanoTechnologies | Series C | 0 |
8/2004 | Pepgen | Series D | 0 |
7/2004 | Intrapace | Series C | 0 |
3/2004 | Reactive NanoTechnologies | Series B | 0 |
1/2003 | Reactive NanoTechnologies | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|